WhatWentBad
Back to search
Class I

Serious health risk

⚠ This recall is currently active

Chiesi USA, Inc.

Drugs recall · D-0689-2026

Reason for recall

Lack of Assurance of Sterility

Product description

CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use Vials, Rx Only, Manufactured for: Chiesi USA, Inc., Cary, NC 27518, by Fresenius Kabi, Graz, Austria, NDC 10122-611-10.

Recalling firm

Chiesi USA, Inc.

Product quantity

44280 vials

Lot / code info

Lot #: 1239521, 1237454, Exp. Date 10/2027

Distribution

Nationwide within the United States

Recall initiated

2026-07-06

Status

Ongoing

Location

Cary, NC, United States

Voluntary / mandated

Voluntary: Firm initiated

Initial notification

Letter

Data from official federal safety records. Updated periodically. Verify on FDA.gov